Hesperos is Biotechnology in United States that focus on efficacy evaluation business. Founded in 2015. They cover business area such as developer, a-chip, toxicology testing, efficacy evaluation, drug discovery, multi-organ system communication, integrate computational PKPD modeling, live physiological response, functional readout, neuron, muscle, barrier tissue, neuromuscular junction, liver, pancreas, their client, vivo function, animal model.
2015
( 9 years old in 2024 )
Efficacy Evaluation
-
12501 Research Parkway
Suite 100
Orlando, FL 32826
United States
Private
developera-chiptoxicology testingefficacy evaluationdrug discoverymulti-organ system communicationintegrate computational PKPD modelinglive physiological responsefunctional readoutneuronmusclebarrier tissueneuromuscular junctionliverpancreastheir clientvivo functionanimal model
* We use standard office opening hours in near Hesperos's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Hesperos is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Hesperos business is focusing on Efficacy Evaluation.
Hesperos headquarter office and corporate office address is located in 12501 Research Parkway Suite 100 Orlando, FL 32826 United States.
Hesperos was founded in United States.
In 2024, Hesperos is currently focus on efficacy evaluation sector.
Above is snippet of Google Trends for "efficacy evaluation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Hesperos, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
